Molecule2Market
Molecule2Market (M2M), established in February 2012, is a boutique CRO dedicated to the research and development of innovative medical treatments for the pharmaceutical, biotechnology and medical device industries. With an…
Overview
Molecule2Market (M2M), established in February 2012, is a boutique CRO dedicated to the research and development of innovative medical treatments for the pharmaceutical, biotechnology and medical device industries. With an average of 20 plus years’ experience, our team members provide high quality services across all phases of clinical research and a broad range of therapeutic areas covering sites in Australia, New Zealand the USA.
M2M services cover the following clinical research activities:
• Project/ site feasibility
• Study start-up, monitoring and close out
• Project management
• Patient recruitment
• Local safety reporting
• Audit/ quality review
• Medical writing
• Local study sponsorship
M2M also offers the following services:
• Regulatory
• Data management/ statistics
• Medical monitoring
• Applying the Australian R&D Tax Incentive when conducting research in Australia
M2M is a proud member of AICROS, the Association of International Contract Research Organizations. AICROS is an alliance of local well established CROs covering Europe, Africa, Israel and India. This membership enables M2M to provide our clients with high quality clinical research services on a global scale.
Delegates



